Varicella zoster virus vaccine live (Bio Pox) - Bio-Med

Drug Profile

Varicella zoster virus vaccine live (Bio Pox) - Bio-Med

Alternative Names: Bio-Pox; Varicella vaccine, live Oka strain - Bio-Med

Latest Information Update: 07 Sep 2016

Price : $50

At a glance

  • Originator Bio-Med
  • Class Varicella vaccines; Viruses
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Varicella zoster virus infections

Most Recent Events

  • 07 Mar 2014 Bio-Med plans a phase III trial for Varicella zoster virus infections (prevention, in infants & children) in India (CTRI2014-03-004445)
  • 16 Nov 2012 Phase-I clinical trials in Varicella zoster virus infections (prevention) in India (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top